Bioactivity | Luvometinib is a mitogen-activated protein kinase (MEK) inhibitor with antitumor activity[1]. |
CAS | 2739690-43-6 |
Formula | C26H22F2IN5O4S |
Molar Mass | 665.45 |
Transport | Room temperature in continental US; may vary elsewhere. |
Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
Reference | [1]. International Nonproprietary Names for Pharmaceutical Substances (INN). WHO Drug Information, Vol. 38, No. 2, 2024. |